Literature DB >> 28875982

Cancer Immunotherapy: From local to global.

Willem J M Mulder1, Sacha Gnjatic2.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28875982     DOI: 10.1038/nnano.2017.196

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN: 1748-3387            Impact factor:   39.213


× No keyword cloud information.
  9 in total

1.  P-selectin is a nanotherapeutic delivery target in the tumor microenvironment.

Authors:  Yosi Shamay; Moshe Elkabets; Hongyan Li; Janki Shah; Samuel Brook; Feng Wang; Keren Adler; Emily Baut; Maurizio Scaltriti; Prakrit V Jena; Eric E Gardner; John T Poirier; Charles M Rudin; José Baselga; Adriana Haimovitz-Friedman; Daniel A Heller
Journal:  Sci Transl Med       Date:  2016-06-29       Impact factor: 17.956

2.  Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer.

Authors:  Xiaopin Duan; Christina Chan; Nining Guo; Wenbo Han; Ralph R Weichselbaum; Wenbin Lin
Journal:  J Am Chem Soc       Date:  2016-12-15       Impact factor: 15.419

3.  Immunologic correlates of the abscopal effect in a patient with melanoma.

Authors:  Michael A Postow; Margaret K Callahan; Christopher A Barker; Yoshiya Yamada; Jianda Yuan; Shigehisa Kitano; Zhenyu Mu; Teresa Rasalan; Matthew Adamow; Erika Ritter; Christine Sedrak; Achim A Jungbluth; Ramon Chua; Arvin S Yang; Ruth-Ann Roman; Samuel Rosner; Brenna Benson; James P Allison; Alexander M Lesokhin; Sacha Gnjatic; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

4.  Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates.

Authors:  Julia Karbach; Sacha Gnjatic; Melina Biskamp; Akin Atmaca; Eckhart Weidmann; Kathrin Brandt; Claudia Wahle; Helga Bernhard; Alexander Knuth; Elke Jäger
Journal:  Cancer Immunol Res       Date:  2014-02-05       Impact factor: 11.151

Review 5.  In situ vaccination for the treatment of cancer.

Authors:  Linda Hammerich; Nina Bhardwaj; Holbrook E Kohrt; Joshua D Brody
Journal:  Immunotherapy       Date:  2016-02-09       Impact factor: 4.196

6.  Enhancing radiotherapy for lung cancer using immunoadjuvants delivered in situ from new design radiotherapy biomaterials: a preclinical study.

Authors:  Yao Hao; Sayeda Yasmin-Karim; Michele Moreau; Neeharika Sinha; Erno Sajo; Wilfred Ngwa
Journal:  Phys Med Biol       Date:  2016-12-02       Impact factor: 3.609

7.  Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated.

Authors:  Sandra Demaria; Bruce Ng; Mary Louise Devitt; James S Babb; Noriko Kawashima; Leonard Liebes; Silvia C Formenti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

8.  The abscopal effect associated with a systemic anti-melanoma immune response.

Authors:  Emily F Stamell; Jedd D Wolchok; Sacha Gnjatic; Nancy Y Lee; Isaac Brownell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-05       Impact factor: 7.038

9.  Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy.

Authors:  Chunbai He; Xiaopin Duan; Nining Guo; Christina Chan; Christopher Poon; Ralph R Weichselbaum; Wenbin Lin
Journal:  Nat Commun       Date:  2016-08-17       Impact factor: 14.919

  9 in total
  5 in total

1.  Combining Nanomedicine and Immunotherapy.

Authors:  Yang Shi; Twan Lammers
Journal:  Acc Chem Res       Date:  2019-05-23       Impact factor: 22.384

Review 2.  Nanomedicine and macroscale materials in immuno-oncology.

Authors:  Qingxue Sun; Matthias Barz; Bruno G De Geest; Mustafa Diken; Wim E Hennink; Fabian Kiessling; Twan Lammers; Yang Shi
Journal:  Chem Soc Rev       Date:  2019-01-02       Impact factor: 54.564

Review 3.  The Landscape of Nanovectors for Modulation in Cancer Immunotherapy.

Authors:  Simona-Ruxandra Volovat; Corina Lupascu Ursulescu; Liliana Gheorghe Moisii; Constantin Volovat; Diana Boboc; Dragos Scripcariu; Florin Amurariti; Cipriana Stefanescu; Cati Raluca Stolniceanu; Maricel Agop; Cristian Lungulescu; Cristian Constantin Volovat
Journal:  Pharmaceutics       Date:  2022-02-11       Impact factor: 6.321

4.  Flavonoid Group of Smilax glabra Roxb. Regulates the Anti-Tumor Immune Response Through the STAT3/HIF-1 Signaling Pathway.

Authors:  Yingxue Guo; Weiye Mao; Lu Jin; Linying Xia; Jie Huang; Xia Liu; Ping Ni; Qiyang Shou; Huiying Fu
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

5.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.